These Four Biotech Stocks Sparkle In IBD 50

Four biotech stocks are hovering near the top of the IBD 50 list of growth stocks, putting on a show of relative strength leadership in this hot industry group. One is near a buy point of a new base, while two others have raced beyond buy ranges in a matter of weeks.


Dynavax Technologies (DVAX), Harmony Biosciences (HRMY), Siga Technologies (SIGA) and Sarepta Therapeutics (SRPT) all sat in or near the top half of the IBD 50 list Friday with Relative Strength Ratings ranging from 97…

Read More